Literature DB >> 15787955

Pharmacy utilization and the Medicare Modernization Act.

Vittorio Maio1, Laura Pizzi, Adam R Roumm, Janice Clarke, Neil I Goldfarb, David B Nash, David Chess.   

Abstract

To control expenditures and use medications appropriately, the Medicare drug coverage program has established pharmacy utilization management (PUM) measures. This article assesses the effects of these strategies on the care of seniors. The literature suggests that although caps on drug benefits lower pharmaceutical costs, they may also increase the use of other health care services and hurt health outcomes. Our review raises concerns regarding the potential unintended effects of the Medicare drug program's PUM policies for beneficiaries. Therefore, the economic and clinical impact of PUM measures on seniors should be studied further to help policymakers design better drug benefit plans.

Mesh：

Year:  2005        PMID： 15787955      PMCID： PMC2690380          DOI： 10.1111/j.0887-378X.2005.00337.x

Source DB:  PubMed          Journal:  Milbank Q        ISSN： 0887-378X            Impact factor:   4.911


  57 in total

1.  A public-policy strategy for drug formularies: preparation or procrastination?

Authors:  T D Rucker
Journal:  Am J Health Syst Pharm       Date:  1999-11-15       Impact factor: 2.637

Review 2.  Drugs and the elderly, Part 1: The problems facing managed care.

Authors:  M H Beers; R W Baran; K Frenia
Journal:  Am J Manag Care       Date:  2000-12       Impact factor: 2.229

3.  Managing prescription drug costs.

Authors:  J M Sica
Journal:  Empl Benefits J       Date:  2001-03

4.  The challenge of expanding health benefits for the aged.

Authors:  T W Elwood
Journal:  J Allied Health       Date:  2000

5.  Therapeutic substitution of cimetidine for nizatidine was not associated with an increase in healthcare utilization.

Authors:  C B Good; S L Fultz; L Trilli; J Etchason
Journal:  Am J Manag Care       Date:  2000-10       Impact factor: 2.229

6.  Exhaustion of prescription benefits and Medicare beneficiaries' disenrollment from managed care.

Authors:  E R Cox; B R Motheral; K Fairman
Journal:  JAMA       Date:  2000 Nov 22-29       Impact factor: 56.272

7.  Health risks, ability to pay, and the use of primary care: is the distribution of service effective and equitable?

Authors:  R W Broyles; L Narine; E N Brandt; D Biard-Holmes
Journal:  Prev Med       Date:  2000-06       Impact factor: 4.018

8.  Adverse events associated with prescription drug cost-sharing among poor and elderly persons.

Authors:  R Tamblyn; R Laprise; J A Hanley; M Abrahamowicz; S Scott; N Mayo; J Hurley; R Grad; E Latimer; R Perreault; P McLeod; A Huang; P Larochelle; L Mallet
Journal:  JAMA       Date:  2001 Jan 24-31       Impact factor: 56.272

9.  Exhaustion of drug benefits and disenrollment of medicare beneficiaries from managed care organizations.

Authors:  T S Rector
Journal:  JAMA       Date:  2000-04-26       Impact factor: 56.272

Review 10.  Generic substitution: issues for problematic drugs.

Authors:  J D Henderson; R H Esham
Journal:  South Med J       Date:  2001-01       Impact factor: 0.954
View more
  9 in total

Review 1.  Drug insurance utilization management policies and "reference pricing": an illustrated commentary on the article by Vittorio Maio and colleagues.

Authors:  Malcolm Maclure
Journal:  Milbank Q       Date:  2005       Impact factor: 4.911

2.  Public/private partnerships for prescription drug coverage: policy formulation and outcomes in Quebec's universal drug insurance program, with comparisons to the Medicare prescription drug program in the United States.

Authors:  Marie-Pascale Pomey; Pierre-Gerlier Forest; Howard A Palley; Elisabeth Martin
Journal:  Milbank Q       Date:  2007-09       Impact factor: 4.911

3.  Potential savings from an evidence-based consumer-oriented public education campaign on prescription drugs.

Authors:  Julie M Donohue; Michael A Fischer; Haiden A Huskamp; Joel S Weissman
Journal:  Health Serv Res       Date:  2008-05-13       Impact factor: 3.402

Review 4.  A systematic umbrella review of the association of prescription drug insurance and cost-sharing with drug use, health services use, and health.

Authors:  G Emmanuel Guindon; Tooba Fatima; Sophiya Garasia; Kimia Khoee
Journal:  BMC Health Serv Res       Date:  2022-03-03       Impact factor: 2.655

5.  Whom do older adults trust most to provide information about prescription drugs?

Authors:  Julie M Donohue; Haiden A Huskamp; Ira B Wilson; Joel Weissman
Journal:  Am J Geriatr Pharmacother       Date:  2009-04

6.  Coverage of atypical antipsychotics among medicare drug plans in the state of washington for fiscal year 2007.

Authors:  Chi-Chuan Wang; Jae Kennedy; Lawrence J Cohen; David A Sclar
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2008

Review 7.  Medication adherence issues in patients treated for COPD.

Authors:  Ruben D Restrepo; Melissa T Alvarez; Leonard D Wittnebel; Helen Sorenson; Richard Wettstein; David L Vines; Jennifer Sikkema-Ortiz; Donna D Gardner; Robert L Wilkins
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2008

Review 8.  Interventions to improve safe and effective medicines use by consumers: an overview of systematic reviews.

Authors:  Rebecca Ryan; Nancy Santesso; Dianne Lowe; Sophie Hill; Jeremy Grimshaw; Megan Prictor; Caroline Kaufman; Genevieve Cowie; Michael Taylor
Journal:  Cochrane Database Syst Rev       Date:  2014-04-29

9.  What impact do prescription drug charges have on efficiency and equity? Evidence from high-income countries.

Authors:  Marin C Gemmill; Sarah Thomson; Elias Mossialos
Journal:  Int J Equity Health       Date:  2008-05-02
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.